This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is MetLife (MET) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how MetLife (MET) and Popular (BPOP) have performed compared to their sector so far this year.
This is Why Popular (BPOP) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
Best Momentum Stock to Buy for September 18th
by Zacks Equity Research
JSAIY, BPOP and NBTB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18, 2024.
New Strong Buy Stocks for September 18th
by Zacks Equity Research
SN, ALX, BPOP, ARCAY and JSAIY have been added to the Zacks Rank #1 (Strong Buy) List on September 18, 2024.
Are Investors Undervaluing Popular (BPOP) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Popular and Lennox International
by Zacks Equity Research
HCA Healthcare, Hubbell, Popular and Lennox International are part of the Zacks Screen of the Week article.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, BPOP and LII are some stocks that hold promise.
Popular (BPOP) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
Is the Options Market Predicting a Spike in Popular (BPOP) Stock?
by Zacks Equity Research
Investors need to pay close attention to Popular (BPOP) stock based on the movements in the options market lately.
Zacks.com featured highlights Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold
by Zacks Equity Research
Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold have been highlighted in this Screen of The Week article.
Popular (BPOP) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Popular (BPOP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Root (ROOT) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Root, Inc. (ROOT) and Popular (BPOP) have performed compared to their sector so far this year.
Bet on These 5 Top-Ranked Value Stocks With Discounted PEG
by Urmimala Biswas
Invest in some top value stocks such as Hilton Grand Vacations (HGV), Tenet Healthcare (THC), Universal Health Services (UHS), Popular, Inc. (BPOP) and B2Gold Corp (BTG) that fit our screening criteria.
Is Popular (BPOP) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
BPOP vs. FBP: Which Stock Is the Better Value Option?
by Zacks Equity Research
BPOP vs. FBP: Which Stock Is the Better Value Option?
Earnings Preview: First Citizens BancShares (FCNCA) Q2 Earnings Expected to Decline
by Zacks Equity Research
First Citizens (FCNCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Popular (BPOP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Popular (BPOP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Makes Popular (BPOP) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Popular (BPOP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Popular (BPOP) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
Is Popular (BPOP) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Popular (BPOP) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes? Let's find out.
Popular (BPOP) Misses Q1 Earnings Estimates
by Zacks Equity Research
Popular (BPOP) delivered earnings and revenue surprises of -4.59% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cadence (CADE) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cadence (CADE) delivered earnings and revenue surprises of 14.81% and 2.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?